Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hohenberger

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Zentralblatt Fur Chirurgie|October 15, 2010
[Leiomyosarcoma of the inferior vena cava]J D Schultz, U Ronellenfitsch, P Hohenberger, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 1, 1992
[The potentials and limits of blood-flow quantification in the peripheral arteries with MRT using a phase-mapping procedure]W Wrazidlo, S Schneider, W Lederer, et al.
European Journal of Radiology|February 16, 2013
CT-based response assessment of advanced gastrointestinal stromal tumor: dual energy CT provides a more predictive imaging biomarker of clinical benefit than RECIST or Choi criteriaM Meyer, P Hohenberger, P Apfaltrer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapiesE Wardelmann, H-U Schildhaus, S Merkelbach-Bruse, et al.
Oncology|June 6, 2000
Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIOH Szelényi, P Hohenberger, H Lochs, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trialP Schlag, M Manasterski, T Gerneth, et al.
Magnetic Resonance Imaging|January 1, 1994
Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinomaH P Schlemmer, P Bachert, W Semmler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinomaA Dimitrakopoulou-Strauss, L G Strauss, P Schlag, et al.
Oncology|July 15, 2000
Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancerA Kretzschmar, P Reichardt, P C Thuss-Patience, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 9, 2006
[Gastrointestinal stromal tumors carrying PDGFRalpha mutations occur preferentially in the stomach and exhibit an epithelioid or mixed phenotype]E Wardelmann, K Pauls, S Merkelbach-Bruse, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Zentralblatt Fur Chirurgie|October 15, 2010
[Leiomyosarcoma of the inferior vena cava]J D Schultz, U Ronellenfitsch, P Hohenberger, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 1, 1992
[The potentials and limits of blood-flow quantification in the peripheral arteries with MRT using a phase-mapping procedure]W Wrazidlo, S Schneider, W Lederer, et al.
European Journal of Radiology|February 16, 2013
CT-based response assessment of advanced gastrointestinal stromal tumor: dual energy CT provides a more predictive imaging biomarker of clinical benefit than RECIST or Choi criteriaM Meyer, P Hohenberger, P Apfaltrer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Soft tissue sarcoma: from molecular diagnosis to selection of treatment. Pathological diagnosis of soft tissue sarcoma amid molecular biology and targeted therapiesE Wardelmann, H-U Schildhaus, S Merkelbach-Bruse, et al.
Oncology|June 6, 2000
Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIOH Szelényi, P Hohenberger, H Lochs, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trialP Schlag, M Manasterski, T Gerneth, et al.
Magnetic Resonance Imaging|January 1, 1994
Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinomaH P Schlemmer, P Bachert, W Semmler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 1998
Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinomaA Dimitrakopoulou-Strauss, L G Strauss, P Schlag, et al.
Oncology|July 15, 2000
Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancerA Kretzschmar, P Reichardt, P C Thuss-Patience, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 9, 2006
[Gastrointestinal stromal tumors carrying PDGFRalpha mutations occur preferentially in the stomach and exhibit an epithelioid or mixed phenotype]E Wardelmann, K Pauls, S Merkelbach-Bruse, et al.
Pageof 16